A Randomised, Double-Blind, Placebo-Controlled, Two-Week Crossover, Knemometric Assessment of the Effect of Fluticasone Furoate Nasal Spray 100mcg Once Daily on Short-Term Growth in Children Aged 6 to 11 Years With Seasonal and/or Perennial Allergic Rhinitis
Phase of Trial: Phase III
Latest Information Update: 26 Sep 2016
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Allergic rhinitis; Rhinitis
- Focus Adverse reactions
- 15 Oct 2008 Actual start date reported as April 2005 by ClinicalTrials.gov.
- 03 Oct 2005 New trial record.